The Impact of the Commercial Model for a Personalized Cancer Vaccine

I think, I think maybe the amount of scrutiny obviously this is Moderna and it's mark and everyone's paying close attention but I wonder what impact the commercial model for a personalized cancer vaccine has on how big of an impact you need to see. The needle to needle times about six weeks. Merck seemed unwurried. They said, you know it's a simpler process than, for example, generating a personalized T cell therapy. We are expecting record attendance at this year's bio equity Europe conference which takes place in mid May with more than 200 CEOs registered today.